Tau Primer 2024 CME, CNE
Activity Available: April 2024 – April 2026
Education Activity Description: Research experts in the field discuss various topics related to Tau Biomarkers; including a clinical overview, drug development, risk and environmental factors, genetics, molecular and cell biology.
Jointly provided by Postgraduate Institute for Medicine and Alzheimer’s Association
Estimated time to complete activity: Approximately 60 minutes per module (1.00 Credits)
Learning Objectives:
Discuss tau-based biology, biomarkers, therapeutics and phenotypes
Determine how to attract talent and funding to the study of tauopathies, particularly among early career researchers
Increase interdisciplinary alignment and collaboration around challenges in tau research
Understand the current state of biomarkers for tau biomarkers derived from neuroimaging and from the analysis of bodily fluids and their roles in the detection, diagnosis and prognosis of tau-associated neurodegenerative disorders
Faculty Disclosure Information
Accreditation Information
Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Target Audience: This activity is intended to meet the educational needs of primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.
Statement of Purpose: A practice gap is the difference between what healthcare professionals should or could be doing and what they are currently doing. Using current evidence-based care recommendations to bridge the gap between patient care and clinical guidelines, ensuring healthcare professionals are not only aware of continues updates in the guidelines but are utilizing them in patient care settings. This will be accomplished by increasing awareness and knowledge of (1) tau-based biology, biomarkers, therapies and phenotypes (2) discuss the current state of biomarkers for tau derived from neuroimaging and (3) develop strategies to increase interdisciplinary alignment in tau research.
Joint Accreditation
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Alzheimer's Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designations:
Physician Continuing Medical Education; The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 contact hour. This activity is being presented without bias and without commercial support.
Credit Claiming Instructions:
Login or Create a New Account (will take less than 1 minute) https://www.cmeuniversity.com/
If you receive a message when creating a new account that “the email you entered is already in use”, please click the forgot my username or password link to have your Username and Password sent to you via email. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page.
Direct link to claim credit: https://www.cmeuniversity.com/course/take/124795
For additional questions please contact clinical education staff at clinicaledu@alz.org